Agilent Expands Oligonucleotide Manufacturing Capabilities With New Boulder Lab
5 October 2026
No Comments
SANTA CLARA, Calif., Oct. 5, 2026 — Agilent Technologies Inc. (NYSE: A) today announced
Tag: Advanced Therapeutics Division